Insmed Stock Already Was Flying High. Sanofi Takeover Buzz Lights the Afterburners.Barrons • Thursday
Insmed Sees BRINSUPRI Reaching $7 Billion in Peak Sales, Expects Cash-Flow Positive Year AheadMarketBeat • Tuesday
Insmed Incorporated (INSM) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha • Monday
INSM Q3 Earnings Miss, Stock Soars on Sales Beat & Raised GuidanceZacks Investment Research • 10/30/26
Insmed (INSM) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 10/29/26
Insmed Reports Third-Quarter 2026 Financial Results and Provides Business UpdatePRNewsWire • 10/29/26
Insmed (INSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 10/22/26
Insmed Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the Treatment of Non-Cystic Fibrosis Bronchiectasis in JapanPRNewsWire • 10/19/26
Insmed Features the Global Phase 3 PALM Clinical Development Program Evaluating Treprostinil Palmitil Inhalation Powder (TPIP) at CHEST 2026PRNewsWire • 10/15/26
Insmed to Present New Data Across Its Respiratory Portfolio at CHEST 2026 and IDWeek 2026PRNewsWire • 10/14/26